Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide
Autor: | Lucia Dello Iacono, Jesús Jiménez-Barbero, Rino Rappuoli, Francesco Berti, Alessia Biolchi, Maria Rosaria Romano, Gonҫalo J. L. Bernardes, Roberto Adamo, Pedro Henriques, Ana Ardá, Ana Gimeno |
---|---|
Přispěvatelé: | European Commission, Repositório da Universidade de Lisboa, Gimeno, Ana [0000-0001-9668-2605], Biolchi, Alessia [0000-0001-5104-5522], Jimenez-Barbero, Jesus [0000-0001-5421-8513], Rappuoli, Rino [0000-0002-8827-254X], Adamo, Roberto [0000-0001-5228-6088], Apollo - University of Cambridge Repository |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
conformation Glycoconjugate design carbohydrates shigella-flexneri Serum Bactericidal Antibody Assay Neisseria meningitidis Crystallography X-Ray medicine.disease_cause 01 natural sciences Epitope Epitopes Immunology and Inflammation Immunogenicity Vaccine NMR-spectroscopy Multicenter Studies as Topic Child Randomized Controlled Trials as Topic chemistry.chemical_classification 0303 health sciences Multidisciplinary biology Polysaccharides Bacterial Acetylation Biological Sciences vaccines Antibodies Bacterial 3. Good health Molecular Docking Simulation Female African meningitis belt Antibody O-acetylation Adolescent medicine.drug_class Meningococcal Vaccines macromolecular substances Meningitis Meningococcal Serogroup 010402 general chemistry Monoclonal antibody antibody recognition Microbiology Immunoglobulin Fab Fragments 03 medical and health sciences Clinical Trials Phase II as Topic antigen Antigen evolution medicine Humans 030304 developmental biology Vaccines Conjugate 0104 chemical sciences structural glycobiology chemistry Polyclonal antibodies biology.protein monoclonal-antibody |
Zdroj: | 'Proceedings of the National Academy of Sciences of the USA ', vol: 117, pages: 29795-29802 (2020) Addi. Archivo Digital para la Docencia y la Investigación instname Proceedings of the National Academy of Sciences of the United States of America Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP Addi: Archivo Digital para la Docencia y la Investigación Universidad del País Vasco |
ISSN: | 0027-8424 |
Popis: | Copyright © 2020 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND). Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis (MenA). Vaccination with glycoconjugates of MenA capsular polysaccharide led to an almost complete elimination of MenA clinical cases. To understand the molecular basis of vaccine-induced protection, we generated a panel of oligosaccharide fragments of different lengths and tested them with polyclonal and monoclonal antibodies by inhibition enzyme-linked immunosorbent assay, surface plasmon resonance, and competitive human serum bactericidal assay, which is a surrogate for protection. The epitope was shown to optimize between three and six repeating units and to be O-acetylated. The molecular interactions between a protective monoclonal antibody and a MenA capsular polysaccharide fragment were further elucidated at the atomic level by saturation transfer difference NMR spectroscopy and X-ray crystallography. The epitope consists of a trisaccharide anchored to the antibody via the O- and N-acetyl moieties through either H-bonding or CH–π interactions. In silico docking showed that 3-O-acetylation of the upstream residue is essential for antibody binding, while O-acetate could be equally accommodated at three and four positions of the other two residues. These results shed light on the mechanism of action of current MenA vaccines and provide a foundation for the rational design of improved therapies. This work was sponsored by GlaxoSmithKline Biologicals and has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie Grant Agreement 675671. |
Databáze: | OpenAIRE |
Externí odkaz: |